NCT05614102BAY2965501pembrolizumabBAY2965501-inducedsolid tumorsIRBs
…ing investigated in a FIH dose-escalation and expansion study ( NCT05614102) to evaluate safety, pharmacokinetics and pharmacodynamics, in …
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05614102 ×
NCT05614102
This institution is selected. Its supporting articles are shown below.